A hi-tech Abu Dhabi firm has helped mastermind a breakthrough in mass screening technology to help boost Covid-19 detection rate both in the UAE and across the globe.
Group 42, an artificial intelligence and cloud computing company in the capital, has joined forces with the UK's Oxford Nanopore Technologies to develop population-wide testing which is set to rolled out within weeks.
The new device can be used on samples from Covid-19 test nasal swabs, and is being further developed to work directly from a saliva sample. The technique uses loop-mediated isothermal amplification, which is a low-cost way of detecting disease in DNA and RNA samples, alongside nanopore sequencing, a faster way of generating an accurate genome sequence than older methods. This kind of testing has previously been used to detect dengue fever and malaria, and one device can process 96 samples in an hour.
It can also assess the presence of the virus on surfaces, or in systems such as water and sewage treatment facilities.
“The collaboration with Oxford Nanopore, a global leader in advanced sequencing products, accelerates G42’s ongoing endeavour to develop impactful applications for public health,” Peng Xiao, chief executive of G42, said.
“The worst of the pandemic has brought out the best in us.”
The new technology is being incorporated into the UAE's public health strategy and aims to enable hundreds of thousands of Covid-19 test samples to be analysed per day.
The UAE has already conducted more than 2.5 million tests since the outbreak began, one of the highest screening rates in the world.
Population-wide testing can help break the transmission patterns of viruses, reducing the number of cases when co-ordinated with a rapid public health response.
However, existing methods make such large-scale processing logistically difficult and cost-prohibitive, according to G42.
The companies said this solution can dramatically reduce the complexity of mass screening.
-
Palestinian women walk next to a graffiti painted by artists amid the ongoing Covid-19 pandemic, in Gaza City. EPA -
Iraqis gather at a coffee shop in Erbil, the capital of the autonomous Kurdish region of northern Iraq. AFP -
Iraqi security forces are deployed to enforce an extended curfew amid the pandemic, in Baghdad. AFP -
Men walk by covered stalls in the Iraqi capital Baghdad. AFP -
Palestinian families enjoy their time at the beach amid the ongoing Covid-19 pandemic in Gaza City. EPA -
Medical staff and patients listen to Ghada Harb, the leader of the Syrian Ghardenia female choir, and the singers of her group as they perform outside of the Children's Hospital in Damascus, Syria, as part of the official 'The culture at your house' initiative aimed at thanking medics and nurses for their efforts in these times of crisis. EPA -
Ghada Harb, the leader of the Syrian Ghardenia female choir, and the singers of her group perform outside of the Children's Hospital in Damascus, Syria. EPA -
A woman and her child are sprayed with disinfectant as they enter a nursery after the government eased the coronavirus restrictions in Amman, Jordan. Reuters -
A teacher wearing a protective suit interacts with a child at a nursery after the government eased the coronavirus restrictions in Amman, Jordan. Reuters -
A woman buys vegetables from a cafe transformed into a fruit and vegetable shop in Cairo, Egypt. Reuters -
Egyptians wearing protective face masks stand outside a post office in Cairo, Egypt. EPA -
Students wearing face masks sit at a classroom at the Tunis Al-Manar university complex in Tunis, Tunisia, after authorities eased measures put in place to prevent the spread of coronavirus pandemic. EPA -
Tunisian player Naim Selliti attends a training session at the Elmanzeh stadium in Tunis, Tunisia. Tunisian national football team resumed training on Monday. EPA -
A Tunisian public health worker disinfects El Menzah Olympic Stadium in Tunis. EPA
G42 and Oxford Nanopore are working on ensuring there is a suitable production capacity for the global deployment of the system once it clears regulatory hurdles.
“Precise and cost-efficient population-scale testing is key to a responsible easing of restrictions, to protect the health of populations and supporting the re-opening of global economic activity,” Dr Gordon Sanghera, chief executive of Oxford Nanopore, said.
“We are confident that our partnership with G42 will allow us to successfully deploy this new technology around the world.”
The UAE is increasingly turning to technology to combat the pandemic.
QuantLase Imaging Lab, the medical research arm of Abu Dhabi's International Holdings Company, announced last month it had developed a rapid laser test to identify Covid-19 patients, which aims to replace the current swab and blood tests that take several hours to process.
The test can be used for mass screenings, with results available in seconds.
The new technology is expected to be introduced to the market in a few months.
